The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

WILL THE STELLAR SAMSUNG GALAXY S8 KILL APPLE’S STOCK RALLY? $SSNLF $AAPL $T $VZ $S $TMUS

April 4, 2017

Samsung last week introduced its new flagship smartphone, the Galaxy S8, after being forced to withdraw the previous model from the market because battery defects caused them to occasionally overheat and combust or explode. The Galaxy S8 is getting glowing reviews. And investors are now asking me whether the Samsung SSNLF smartphone will hurt sales of the Apple AAPL  iPhone and, potentially, halt the Apple stock rally. In this column, I’ll focus on the latter theme. Let’s start with an Apple chart and then explore fundamental, quantitative, sentiment and ownership factors. Apple chart Please click here for the annotated Apple chart. Note the following from

Read More »

GREAT PROFITS ON OUR SHORT ON MS WALKING DRUG COMPANY ACORDA, STOCK CRUSHED ON PATENT RULING $ACOR

April 3, 2017

This post was just published on ZYX Short Sell Change Alert. ACOR is short from $48.73.  The stock was halted at $20.33, down $6.44.  The stock was being crushed before the halt as patents on Ampyra are invalidated.  ACOR came to fame on Ampyra, a drug that marginally helps MS patients’ walking. We have a long history with shorting this stock. Before the halt the stock had fallen into the target zone of $14 to $21.   20% of the full core position size is being held. What To Do Now If the stock opens lower or right around the close before the halt,

Read More »

WEEKLY MARKET DIGEST: TRUMP XI SUMMIT THE NEXT MARKET MOVER, OIL HIGHER ON KUWAIT, SILVER BUYING $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO

March 31, 2017

  Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. POSITION SQUARING, TRUMP XI SUMMIT AHEAD, ZUMA AX, GOLD UNDER PRESSURE March 31, 2017 This is what you need to know today. Position Squaring In

Read More »

ADVANCED ACCELERATOR APPLICATIONS, STEVE JOBS CANCER DRUG COMPANY, BREAKING OUT $AAAP $AAPL $XBI $IBB

March 30, 2017

This post was just published on ZYX Buy Change Alert.  AAAP, Steve Jobs cancer drug company, appears to be breaking out.  Please see prior post on AAAP. This information is useful only for short-term aggressive traders. Long-term conservative investors may ignore this post. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE  30 day trial. Check out our enviable performance in both bull and bear markets.

Read More »

ASK ARORA: PROFESSIONALS EATING MOM AND POP’S LUNCH AS DOW JUMPS 340 POINTS $VXX $XOP $IBB $DUST $NUGT $GDX $GDXJ $SLV $GLD $SPY

March 29, 2017

Many investors have seen their “stops” — orders to sell securities to protect from losses — triggered only to see the stock market reverse course and post gains. Other investors have ended up selling securities on technical signals, and then the market does the opposite. I have received many questions from frustrated investors seeking a solution. I have some tips. But first, let’s explore a real market occurrence. The annotated chart of S&P 500 ETF SPY,  shows the market conditions. (Please click here for the chart.) Professionals recently had a field day eating the lunch of mom-and-pop investors as the

Read More »

UPDATE ON GOLD MINER TRIPLE LEVERAGED ETF NUGT TRADE $NUGT $GOLD $SLV $DUST $GDX $GDXJ $GLD

March 28, 2017

This post was published on ZYX Buy Change Alert. Please note change in very, very short-term rating on gold and silver, please see prior post. Profits have already been taken on three-quarters of the NUGT position.  There is a tight stop on the remaining. Regarding the remaining, please consult gold and silver ratings and make that decision based on your own time frame. For performance tracking purposes, we are booking profits on the remaining position right here.  If you are deciding that your time frame is different, please be sure to have the stop so that your trade is profitable even if

Read More »

MARKET’S REAL PROBLEM IS OBAMA BUT TRUMP MIGHT STILL PREVAIL $UUP $NUGT $DUST $WFT $MU $BAC $JPM $FCX $XME $AKS $MT $X $CLF $JJC

March 27, 2017

The stock market’s real problem is Barack Obama. Let me explain: For eight years the Republicans were united in their dislike of him, but now that he’s gone, they’re have difficulty staying united. The failure of the health-care bill Friday is proof positive that the Republicans are having a tough time without Obama around. Now that the health-care plan has failed, investors’ focus will be on tax reform. President Trump may be able to lower corporate taxes, which would help the market the most. In addition, if he can make progress toward deregulation and infrastructure spending, the stock market would

Read More »

UPDATE ON HEDGES, REVIEWED DAILY AFTER THE ORIGINAL PUBLICATION DATE $VXX $GLD $GDX $SPY

March 25, 2017

This post was just published on ZYX Buy Change Alert. Those who do not hedge and are using cash as their defense may ignore this post but review their cash levels.  For guidance please see the ‘What To Do Now’ section of the latest Morning Capsule. Consider short to medium- term hedges of 15% – 25% plus very short-term hedges of 15%. This is in addition to the SCO hedge. TO BE ABSOLUTELY CLEAR, THIS IS NOT A CALL ON THE MARKET DIRECTION BUT SIMPLY A PRUDENT PRACTICE TO PRESERVE AND BUILD WEALTH OVER THE LONG-TERM. HEDGES ARE LIKE AN INSURANCE POLICY AND USUALLY

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content